Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 3/20 | 0.70 |
| ▸ | PRKCE | Q02156 | 2/20 | 0.70 |
| ▸ | PRKCQ | Q04759 | 2/20 | 0.70 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.64 |
| ▸ | LMNA | P02545 | 1/20 | 0.64 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.63 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.63 |
| ▸ | DGKA | P23743 | 1/20 | 0.62 |
| ▸ | SELP | P16109 | 1/20 | 0.60 |
| ▸ | LPAR1 | Q92633 | 4/20 | 0.56 |
| ▸ | FAAH | O00519 | 1/20 | 0.56 |
| ▸ | CES2 | O00748 | 1/20 | 0.56 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.56 |
| ▸ | LPAR4 | Q99677 | 1/20 | 0.56 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.56 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.56 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8734221 | 1.00 | PRKCA (0.70) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL17518704 | 1.00 | PRKCA (0.70) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL11946617 | 1.00 | PRKCA (0.70) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL12836586 | 1.00 | PRKCA (0.70) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL23962839 | 1.00 | PRKCA (0.70) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL23963008 | 1.00 | PRKCA (0.70) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL2770151 | 1.00 | PRKCA (0.70) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL12939325 | 1.00 | PRKCA (0.70) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL5414095 | 1.00 | PRKCA (0.70) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL14105342 | 1.00 | PRKCA (0.70) | PRKCAPRKCEPRKCQPRKCDALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160367678-A1 | BOLAAMPHIPHILIC COMPOUNDS, COMPOSITIONS AND USES THEREOF | LAUREN SCIENCES LLC (US) | 2016-12-22 | — | — | US | disclosed |
| US-20160367678-A1 | BOLAAMPHIPHILIC COMPOUNDS, COMPOSITIONS AND USES THEREOF | LAUREN SCIENCES LLC (US) | 2016-12-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160367678-A1 | BOLAAMPHIPHILIC COMPOUNDS, COMPOSITIONS AND USES THEREOF | GFRA2, GFRA1, NGF | PRKCA 4302/4885PRKCE 4637/4885PRKCQ 4660/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.